Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2024 Filed Oct 9, 2024 22:00 UTC |
Stewart Michael GDirector
|
SaleCommon stock, par value $0.001 | 32,780 | $5.46 | $178,978.80 |
DisclosureSEC source: 0000950170-24-113821 · ownership.xml · nonDerivative · entry 1 Stewart Michael G · CIK 0001331453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,245 Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 21:00 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
Tax withholdingCommon stock, par value $0.001 | 22,665 | $5.90 | $133,723.50 |
DisclosureSEC source: 0000950170-24-112455 · ownership.xml · nonDerivative · entry 1 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,681,328 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 21:00 UTC |
Hanna James KevinSenior VP, Controller & CAO
|
Tax withholdingCommon stock, par value $0.001 | 1,682 | $5.90 | $9,923.80 |
DisclosureSEC source: 0000950170-24-112451 · ownership.xml · nonDerivative · entry 1 Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,554 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 21:00 UTC |
Williams Rosa HandleySVP of Operations
|
Tax withholdingCommon stock, par value $0.001 | 1,230 | $5.90 | $7,257.00 |
DisclosureSEC source: 0000950170-24-112456 · ownership.xml · nonDerivative · entry 1 Hooper Rosa Handley · CIK 0001969905 · SVP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359,600 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 21:00 UTC |
LAMBERT CHARLES RSVP of Finance and Treasurer
|
Tax withholdingCommon stock, par value $0.001 | 500 | $5.90 | $2,950.00 |
DisclosureSEC source: 0000950170-24-112454 · ownership.xml · nonDerivative · entry 1 LAMBERT CHARLES R · CIK 0001225492 · SVP of Finance and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,474 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 21:00 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
Tax withholdingCommon stock, par value $0.001 | 51,092 | $5.90 | $301,442.80 |
DisclosureSEC source: 0000950170-24-112453 · ownership.xml · nonDerivative · entry 1 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,805,041 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| October 02, 2024 Filed Oct 3, 2024 21:00 UTC |
Portal Larry HSVP, Senior Advisor to the CEO
|
Tax withholdingCommon stock, par value $0.001 | 2,172 | $5.90 | $12,814.80 |
DisclosureSEC source: 0000950170-24-112452 · ownership.xml · nonDerivative · entry 1 Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 416,074 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| September 18, 2024 Filed Sep 19, 2024 18:01 UTC |
Pitman Elizabeth NDirector
|
PurchaseCommon stock, par value $0.001 | 8,087 | $6.01 | $48,602.87 |
DisclosureSEC source: 0000950170-24-108220 · ownership.xml · nonDerivative · entry 1 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,740 Read SEC document |
| August 27, 2024 Filed Aug 27, 2024 22:44 UTC |
THOMPSON C REYNOLDS IIIDirector
|
SaleCommon stock, par value $0.001 | 20,530 | $4.38 | $89,921.40 |
DisclosureSEC source: 0000950170-24-101158 · ownership.xml · nonDerivative · entry 1 THOMPSON C REYNOLDS III · CIK 0001188038 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,637 F1 · shares: The sale was made in connection with the reporting person's year-end tax planning for 2024. The reporting person intends but is not required to repurchase an equal number of shares, subject to compliance with laws and company policies, as well as then-market conditions. Read SEC document |
| August 15, 2024 Filed Aug 15, 2024 18:34 UTC |
Pitman Elizabeth NDirector
|
SaleCommon stock, par value $0.001 | 10,025 | $4.98 | $49,924.50 |
DisclosureSEC source: 0000950170-24-097720 · ownership.xml · nonDerivative · entry 1 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,653 F1 · shares: The sale was made in connection with the reporting person's year-end tax planning for 2024. The reporting person intends but is not required to repurchase an equal number of shares, subject to compliance with laws and company policies, as well as then-market conditions. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:03 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
Tax withholdingCommon stock, par value $0.001 | 22,665 | $4.46 | $101,085.90 |
DisclosureSEC source: 0000950170-24-082207 · ownership.xml · nonDerivative · entry 1 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,703,993 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:04 UTC |
Hanna James KevinSenior VP, Controller & CAO
|
Tax withholdingCommon stock, par value $0.001 | 1,682 | $4.46 | $7,501.72 |
DisclosureSEC source: 0000950170-24-082208 · ownership.xml · nonDerivative · entry 1 Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,236 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:05 UTC |
Williams Rosa HandleySVP of Operations
|
Tax withholdingCommon stock, par value $0.001 | 1,230 | $4.46 | $5,485.80 |
DisclosureSEC source: 0000950170-24-082209 · ownership.xml · nonDerivative · entry 1 Hooper Rosa Handley · CIK 0001969905 · SVP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,830 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:06 UTC |
Portal Larry HSVP, Senior Advisor to the CEO
|
Tax withholdingCommon stock, par value $0.001 | 2,172 | $4.46 | $9,687.12 |
DisclosureSEC source: 0000950170-24-082210 · ownership.xml · nonDerivative · entry 1 Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 418,246 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| July 03, 2024 Filed Jul 8, 2024 22:03 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
Tax withholdingCommon stock, par value $0.001 | 51,092 | $4.46 | $227,870.32 |
DisclosureSEC source: 0000950170-24-082205 · ownership.xml · nonDerivative · entry 1 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,856,133 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 22:30 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
Tax withholdingCommon stock, par value $0.001 | 22,665 | $4.73 | $107,205.45 |
DisclosureSEC source: 0000950170-24-047147 · ownership.xml · nonDerivative · entry 2 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,726,658 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 22:30 UTC |
Hanna James KevinSenior VP, Controller & CAO
|
Tax withholdingCommon stock, par value $0.001 | 1,682 | $4.73 | $7,955.86 |
DisclosureSEC source: 0000950170-24-047146 · ownership.xml · nonDerivative · entry 2 Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,918 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 22:30 UTC |
Williams Rosa HandleySVP of Operations
|
Tax withholdingCommon stock, par value $0.001 | 1,230 | $4.73 | $5,817.90 |
DisclosureSEC source: 0000950170-24-047149 · ownership.xml · nonDerivative · entry 2 Hooper Rosa Handley · CIK 0001969905 · SVP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,060 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 22:30 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
Tax withholdingCommon stock, par value $0.001 | 51,092 | $4.73 | $241,665.16 |
DisclosureSEC source: 0000950170-24-047148 · ownership.xml · nonDerivative · entry 2 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,907,225 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 22:30 UTC |
Portal Larry HSVP, Senior Advisor to the CEO
|
Tax withholdingCommon stock, par value $0.001 | 2,172 | $4.73 | $10,273.56 |
DisclosureSEC source: 0000950170-24-047145 · ownership.xml · nonDerivative · entry 2 Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,418 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 22:30 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
Tax withholdingCommon stock, par value $0.001 | 89,785 | $4.98 | $447,129.30 |
DisclosureSEC source: 0000950170-24-047147 · ownership.xml · nonDerivative · entry 1 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,749,323 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 22:30 UTC |
Hanna James KevinSenior VP, Controller & CAO
|
Tax withholdingCommon stock, par value $0.001 | 7,102 | $4.98 | $35,367.96 |
DisclosureSEC source: 0000950170-24-047146 · ownership.xml · nonDerivative · entry 1 Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,600 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 22:30 UTC |
Williams Rosa HandleySVP of Operations
|
Tax withholdingCommon stock, par value $0.001 | 5,356 | $4.98 | $26,672.88 |
DisclosureSEC source: 0000950170-24-047149 · ownership.xml · nonDerivative · entry 1 Hooper Rosa Handley · CIK 0001969905 · SVP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,290 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 22:30 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
Tax withholdingCommon stock, par value $0.001 | 239,033 | $4.98 | $1,190,384.34 |
DisclosureSEC source: 0000950170-24-047148 · ownership.xml · nonDerivative · entry 1 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,958,317 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| April 19, 2024 Filed Apr 23, 2024 22:30 UTC |
Portal Larry HSVP, Senior Advisor to the CEO
|
Tax withholdingCommon stock, par value $0.001 | 9,229 | $4.98 | $45,960.42 |
DisclosureSEC source: 0000950170-24-047145 · ownership.xml · nonDerivative · entry 1 Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 422,590 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:31 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GrantCommon stock, par value $0.001 | 51,887 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039719 · ownership.xml · nonDerivative · entry 2 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,839,108 F2 · shares: Represents additional shares earned and vested immediately under the 2023 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement, decreased pursuant to the modifier provisions in the award that were based on the Company's total return to shareholders. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:31 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GrantCommon stock, par value $0.001 | 6,560 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039719 · ownership.xml · nonDerivative · entry 1 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,787,221 F1 · shares: Represents net additional shares earned and vested immediately under the 2021 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement, decreased pursuant to the modifier provisions in the award that were based on the Company's total return to shareholders. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:31 UTC |
Hanna James KevinSenior VP, Controller & CAO
|
GrantCommon stock, par value $0.001 | 8,717 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039720 · ownership.xml · nonDerivative · entry 2 Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 390,702 F2 · shares: Represents additional shares earned and vested immediately under the 2023 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:31 UTC |
Hanna James KevinSenior VP, Controller & CAO
|
GrantCommon stock, par value $0.001 | 1,933 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039720 · ownership.xml · nonDerivative · entry 1 Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 381,985 F1 · shares: Represents net additional shares earned and vested immediately under the 2021 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:32 UTC |
Portal Larry HSVP, Senior Advisor to the CEO
|
GrantCommon stock, par value $0.001 | 8,717 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039721 · ownership.xml · nonDerivative · entry 2 Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,819 F2 · shares: Represents additional shares earned and vested immediately under the 2023 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:32 UTC |
Portal Larry HSVP, Senior Advisor to the CEO
|
GrantCommon stock, par value $0.001 | 2,333 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039721 · ownership.xml · nonDerivative · entry 1 Portal Larry H · CIK 0001969950 · SVP, Senior Advisor to the CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 423,102 F1 · shares: Represents net additional shares earned and vested immediately under the 2021 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:33 UTC |
Williams Rosa HandleySVP of Operations
|
GrantCommon stock, par value $0.001 | 5,884 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039722 · ownership.xml · nonDerivative · entry 2 Hooper Rosa Handley · CIK 0001969905 · SVP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 368,646 F2 · shares: Represents additional shares earned and vested immediately under the 2023 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:33 UTC |
Williams Rosa HandleySVP of Operations
|
GrantCommon stock, par value $0.001 | 1,866 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039722 · ownership.xml · nonDerivative · entry 1 Hooper Rosa Handley · CIK 0001969905 · SVP of Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,762 F1 · shares: Represents net additional shares earned and vested immediately under the 2021 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:30 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantCommon stock, par value $0.001 | 103,774 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039718 · ownership.xml · nonDerivative · entry 2 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,197,350 F2 · shares: Represents additional shares earned and vested immediately under the 2023 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement, decreased pursuant to the modifier provisions in the award that were based on the Company's total return to shareholders. Read SEC document |
| March 28, 2024 Filed Apr 2, 2024 01:30 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantCommon stock, par value $0.001 | 13,119 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-039718 · ownership.xml · nonDerivative · entry 1 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,093,576 F1 · shares: Represents net additional shares earned and vested immediately under the 2021 performance award based on the Company's actual performance as compared to the performance hurdles defined in the award agreement, decreased pursuant to the modifier provisions in the award that were based on the Company's total return to shareholders. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 18:00 UTC |
DAWSON G STEVENDirector
|
GrantCommon stock, par value $0.001 | 29,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-032371 · ownership.xml · nonDerivative · entry 1 DAWSON G STEVEN · CIK 0001020944 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,362 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2024. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 18:00 UTC |
Mozingo Caterina ArdonDirector
|
GrantCommon stock, par value $0.001 | 29,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-032376 · ownership.xml · nonDerivative · entry 1 Mozingo Caterina Ardon · CIK 0001804387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,310 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2024. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 18:00 UTC |
Pitman Elizabeth NDirector
|
GrantCommon stock, par value $0.001 | 29,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-032375 · ownership.xml · nonDerivative · entry 1 Pitman Elizabeth N · CIK 0001732148 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,678 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2024. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 22:00 UTC |
Stewart Michael GDirector
|
GrantCommon stock, par value $0.001 | 29,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-032373 · ownership.xml · nonDerivative · entry 1 Stewart Michael G · CIK 0001331453 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,025 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2024. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 22:00 UTC |
SPARKS DANIEL PAULDirector
|
GrantCommon stock, par value $0.001 | 29,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-032377 · ownership.xml · nonDerivative · entry 1 SPARKS DANIEL PAUL · CIK 0001619358 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,388 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2024. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 22:00 UTC |
THOMPSON C REYNOLDS IIIDirector
|
GrantCommon stock, par value $0.001 | 29,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-032370 · ownership.xml · nonDerivative · entry 1 THOMPSON C REYNOLDS III · CIK 0001188038 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,167 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2024. Read SEC document |
| March 15, 2024 Filed Mar 15, 2024 22:00 UTC |
Murphy Emily WebsterDirector
|
GrantCommon stock, par value $0.001 | 29,914 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-032374 · ownership.xml · nonDerivative · entry 1 Murphy Emily Webster · CIK 0001914520 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,670 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2024. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 00:34 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GrantRestricted common stock units · Derivative | 900,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030346 · ownership.xml · derivative · entry 2 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Common stock, par value $0.001 · 900,000 shares Expires not disclosed F2 · shares: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period following March 8, 2024 (the "Grant Date") as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 3). F3 · shares: Earned restricted stock units will be settled in cash in equal quarterly installments over two years following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. F2 · derivative.exercise_date: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period following March 8, 2024 (the "Grant Date") as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 3). F3 · derivative.exercise_date: Earned restricted stock units will be settled in cash in equal quarterly installments over two years following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. F2 · derivative.expiration_date: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period following March 8, 2024 (the "Grant Date") as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 3). F3 · derivative.expiration_date: Earned restricted stock units will be settled in cash in equal quarterly installments over two years following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 00:34 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GrantCommon stock, par value $0.001 | 436,603 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030346 · ownership.xml · nonDerivative · entry 1 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,780,661 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2024. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 00:33 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantRestricted common stock units · Derivative | 1,800,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030343 · ownership.xml · derivative · entry 2 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800,000 Underlying: Common stock, par value $0.001 · 1,800,000 shares Expires not disclosed F2 · shares: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period following March 8, 2024 (the "Grant Date") as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 3). F3 · shares: Earned restricted stock units will be settled in cash in equal quarterly installments over two years following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. F2 · derivative.exercise_date: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period following March 8, 2024 (the "Grant Date") as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 3). F3 · derivative.exercise_date: Earned restricted stock units will be settled in cash in equal quarterly installments over two years following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. F2 · derivative.expiration_date: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period following March 8, 2024 (the "Grant Date") as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 3). F3 · derivative.expiration_date: Earned restricted stock units will be settled in cash in equal quarterly installments over two years following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 00:33 UTC |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantCommon stock, par value $0.001 | 873,206 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030343 · ownership.xml · nonDerivative · entry 1 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,080,457 F1 · shares: Shares vest ratably at the beginning of each of the 12 calendar quarters beginning April 1, 2024. Read SEC document |
| March 08, 2024 Filed Mar 15, 2024 01:00 UTC Amendment |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
GrantRestricted common stock units · Derivative | 900,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-031823 · ownership.xml · derivative · entry 1 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Common stock, par value $0.001 · 900,000 shares Expires not disclosed F1 · shares: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period ending on December 31, 2027 (previously reported as March 8, 2028) as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 2). F2 · shares: Earned restricted stock units will be settled in cash in equal quarterly installments over one year (previously reported as two years) following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. F1 · derivative.exercise_date: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period ending on December 31, 2027 (previously reported as March 8, 2028) as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 2). F2 · derivative.exercise_date: Earned restricted stock units will be settled in cash in equal quarterly installments over one year (previously reported as two years) following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. F1 · derivative.expiration_date: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period ending on December 31, 2027 (previously reported as March 8, 2028) as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 2). F2 · derivative.expiration_date: Earned restricted stock units will be settled in cash in equal quarterly installments over one year (previously reported as two years) following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. Read SEC document |
| March 08, 2024 Filed Mar 15, 2024 01:00 UTC Amendment |
Aldag Edward K JRDirector · Chairman, President & CEO
|
GrantRestricted common stock units · Derivative | 1,800,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-031824 · ownership.xml · derivative · entry 1 Aldag Edward K JR · CIK 0001331608 · Director · Chairman, President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,800,000 Underlying: Common stock, par value $0.001 · 1,800,000 shares Expires not disclosed F1 · shares: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period ending on December 31, 2027 (previously reported as March 8, 2028) as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 2). F2 · shares: Earned restricted stock units will be settled in cash in equal quarterly installments over one year (previously reported as two years) following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. F1 · derivative.exercise_date: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period ending on December 31, 2027 (previously reported as March 8, 2028) as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 2). F2 · derivative.exercise_date: Earned restricted stock units will be settled in cash in equal quarterly installments over one year (previously reported as two years) following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. F1 · derivative.expiration_date: The restricted stock units were granted under the Medical Properties Trust, Inc. Amended and Restated 2019 Equity Incentive Plan and will be earned based on the achievement of specified increases in the price of the Company's common stock during the four-year period ending on December 31, 2027 (previously reported as March 8, 2028) as follows: (i) if the Company's share price increases to $7.00, 100% of the restricted stock units will be earned; (ii) if the Company's share price increases to $8.50, 200% of the restricted stock units will be earned; and (iii) if the Company's share price increases to $10.00, 300% of the restricted stock units will be earned. The actual number of restricted stock units to be earned will be determined based on the trailing 20-trading day average closing price of the Company's common stock (continued on footnote 2). F2 · derivative.expiration_date: Earned restricted stock units will be settled in cash in equal quarterly installments over one year (previously reported as two years) following the date the restricted stock units are earned, subject to the grantee's continued employment through such date, provided that all unsettled earned restricted stock units will be settled in cash in full on the date that the Compensation Committee makes the final determination regarding achievement of the performance metrics following the end of the four year performance period. Each restricted stock unit will be settled in cash based on the value of a share of common stock. Read SEC document |
| January 08, 2024 Filed Jan 8, 2024 23:18 UTC |
HAMNER R STEVENDirector · Executive Vice President & CFO
|
Tax withholdingCommon stock, par value $0.001 | 8,795 | $4.98 | $43,799.10 |
DisclosureSEC source: 0000950170-24-003092 · ownership.xml · nonDerivative · entry 1 HAMNER R STEVEN · CIK 0001067414 · Director · Executive Vice President & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,344,058 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
| January 08, 2024 Filed Jan 8, 2024 23:19 UTC |
Hanna James KevinSenior VP, Controller & CAO
|
Tax withholdingCommon stock, par value $0.001 | 2,402 | $4.98 | $11,961.96 |
DisclosureSEC source: 0000950170-24-003093 · ownership.xml · nonDerivative · entry 1 Hanna James Kevin · CIK 0001665881 · Senior VP, Controller & CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 380,052 F1 · shares: Represents shares withheld upon vesting of restricted stock to satisfy tax withholding obligations. This does not constitute a sale transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.